Vialwirebiotech, curated
July 22, 2026, 3:20 AM
June 25, 2026
- 1:09 PM · SCMP — Tech
- 12:38 PM · SCMP — Tech12:38 PMDeepSeek hiring spree: Chinese AI firm seeks newcomers as it pursues AGI — SCMP — Tech
- 12:00 PM · BioWorld12:00 PMIonis wins wider Tryngolza approval for hypertriglyceridemia — BioWorld
- 12:00 PM · BioWorld12:00 PMUncertainty reigns as ACIP remains on court hold — BioWorld
- 12:00 PM · BioWorld12:00 PMBIO 2026: Industry negotiators preview PDUFA VIII — BioWorld
- 11:03 AM · STAT News
- 10:55 AM · BioPharma Dive10:55 AMRemix to go public in reverse merger with once high-flying Passage Bio — BioPharma Dive
- 10:00 AM · SCMP — Tech10:00 AMChinese physical AI start-up proposes new paradigm that bypasses OpenAI, Meta road maps — SCMP — Tech
- 9:58 AM · NYT — Science9:58 AMTrump Administration Forms Partnership to Bank DNA From Imperiled Species — NYT — Science
- 9:00 AM · SCMP — Tech9:00 AMChina’s cybersecurity industry needs its own Mythos model, 360 founder warns — SCMP — Tech
- 9:00 AM · BioWorld9:00 AMMerck KGaA announces cardio partnership with Saturnus Bio — BioWorld
- 9:00 AM · BioWorld9:00 AMSeries A financing at RQ Bio to advance RQB-01 for flu prevention — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA clears IND for Ascletis Pharma’s ASC-35 for obesity — BioWorld
- 9:00 AM · BioWorld9:00 AMUnixell’s UX-DA003 cleared for clinic in US and China — BioWorld
- 9:00 AM · BioWorld9:00 AMBMS’s dual CAR T-cell therapy shows efficacy in multiple myeloma — BioWorld
- 9:00 AM · BioWorld9:00 AMMJFF grant to advance X-tosis’ XTS-001 for Parkinson’s — BioWorld
- 9:00 AM · BioWorld9:00 AMCombotope and Boehringer Ingelheim partner in cancer — BioWorld
- 9:00 AM · BioWorld9:00 AMNippon Shinyaku’s NS-035 designated orphan drug in Japan — BioWorld
- 8:33 AM · Pharmaceutical Executive8:33 AM<![CDATA[FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer]]> — Pharmaceutical Executive
- 8:00 AM · STAT News
- 6:16 AM · FT — Pharmaceuticals6:16 AMGerman group Merck to buy Bio-Techne in $11.3bn deal — FT — Pharmaceuticals
- 6:16 AM · FT — Pharmaceuticals6:16 AMGerman drugmaker Merck to buy Bio-Techne in $11.3bn deal — FT — Pharmaceuticals
- 5:55 AM · Pharmaceutical Executive5:55 AM<![CDATA[Ibrance Wins FDA Approval for HR-Positive, HER2-Positive Metastatic Breast Cancer Maintenance Therapy]]> — Pharmaceutical Executive
- 5:23 AM · Pharmaceutical Technology5:23 AMMSD’s Keytruda-Padcev combo secures EC approval for MIBC — Pharmaceutical Technology
- 2:57 AM · Bloomberg — Technology2:57 AMH.B. Fuller Agrees to Acquire UK-Listed AMS for £659 Million — Bloomberg — Technology
June 24, 2026
- 4:01 PM · STAT News
- 12:32 PM · STAT News12:32 PMClinical trial set to test two drugs for fast-growing Ebola outbreak — STAT News
- 12:00 PM · BioWorld12:00 PMAntares, Novartis pursuing undruggable cancer targets in $1.9B deal — BioWorld
- 12:00 PM · BioWorld12:00 PMTissium secures €60M to advance sutureless tissue repair platform — BioWorld
- 12:00 PM · BioWorld12:00 PMLilly taps Abbisko for $1.9B discovery deal — BioWorld
- 12:00 PM · BioWorld12:00 PMLilly’s GLP-1 windfall fuels M&A ‘land grab’ across 10 deals, $25B — BioWorld
- 11:46 AM · Drug Discovery World11:46 AMLonza and InduPro to collaborate on next-gen ADC therapies — Drug Discovery World
- 9:00 AM · PharmaVoice9:00 AMRecent pharma exec shake-ups signal strategic shifts — PharmaVoice
- 8:12 AM · BioPharma Dive8:12 AMSangamo holds a bankruptcy sale; VCs back a China-linked Beam competitor — BioPharma Dive
- 8:00 AM · FT — Pharmaceuticals8:00 AMStripe and Anthropic invest in combating respiratory diseases — FT — Pharmaceuticals
- 7:00 AM · BioPharma Dive7:00 AMOllin refuels with $330M to back pivotal tests of Vabysmo challenger — BioPharma Dive
- 6:34 AM · Pharmaceutical Technology6:34 AMŌURA and Lilly join forces to harmonise drug-wearable obesity care — Pharmaceutical Technology
- 5:53 AM · Drug Discovery World5:53 AMNura Bio raises $73.8m, advances pipeline of SARM1 inhibitors — Drug Discovery World
- 4:31 AM · Drug Discovery World4:31 AMTRIMTECH raises $47m for protein degradation portfolio — Drug Discovery World
- 4:10 AM · Pharmaceutical Technology4:10 AMHaisco and Nuvectis sign licensing deal for two drugs — Pharmaceutical Technology